In this free webinar, learn the importance of early medical affairs engagement. Attendees will learn how to prioritize tactics that maximize value within constrained budgets, ensuring that every dollar spent contributes to building a strong foundation for future success. Understand how to drive company and scientific awareness thoughtfully in a crowded market. The featured speakers will share actionable advice and best practices from industry experts who understand the challenges facing small and mid-sized companies.
TORONTO, June 19, 2024 /PRNewswire-PRWeb/ -- In today's pharmaceutical market, innovative new treatments with the potential to improve patients' lives face unprecedented obstacles, including greater complexity and cost, more stringent evidence requirements to secure patient access beyond regulatory approval, a greater diversity of stakeholders and decision-makers and competition for share of voice.
Strategic, early medical affairs engagement can be the difference between a successful market entry and getting lost in the noise. Join this webinar for an insightful discussion with industry experts as they delve into the art and science of early medical affairs engagement, even when faced with limited resources.
In this webinar, the attendees will discover how small and mid-sized (SMID) companies can leverage thoughtful medical affairs planning and prioritization to drive significant impact and raise asset valuation on their journey to commercialization, including:
- Effective Prioritization on a Budget: How to prioritize tactics that deliver maximum value and ensure each investment enhances early medical affairs efforts and sets the stage for future success
- Navigating a Competitive Market: Strategies for driving company and scientific awareness in a crowded market, with an eye toward how to position the company and products effectively to stand out from the competition
- Real-World Examples and Expert Advice: Case studies and key learnings from industry experts who have been there, understand the challenges faced by SMID companies and can offer actionable advice and best practices
Benefit from the experiences of expert speakers who have successfully navigated the complexities of early market engagement.
Register for this webinar today to learn how small and mid-sized companies can effectively prioritize and leverage medical affairs strategies to enhance asset valuation and navigate competition.
Join Anshu Sawhney, Vice President, Syneos One Medical Affairs, Syneos Health, Dr. Diego Grauman, MD, VP, Senior Medical Affairs Lead, Syneos Health; and Rohan Gandhi, PhD, VP, Medical Affairs, Cloudbreak Therapeutics, for the live webinar on Wednesday, July 10, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit From Insight to Impact: Leveraging Early Medical Affairs Engagement for Future Commercial Success.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article